Display options
Cite
Tigova O, Amalia B, Castellano Y, et al. Secondhand exposure to e-cigarette aerosols among smokers: A cross-sectional study in six European countries of the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis. 2019;16:A11doi: 10.18332/tid/99117.
Tigova, O., Amalia, B., Castellano, Y., Fu, M., Nogueira, S. O., Kyriakos, C. N., Mons, U., Trofor, A. C., Zatoński, W. A., Przewoźniak, K., Demjén, T., Tountas, Y., Quah, A. C. K., Fong, G. T., Fernández, E., Vardavas, C. I. (2018). Secondhand exposure to e-cigarette aerosols among smokers: A cross-sectional study in six European countries of the EUREST-PLUS ITC Europe Surveys. Tobacco induced diseases, 16A11. https://doi.org/10.18332/tid/99117
Tigova, Olena, et al. "Secondhand exposure to e-cigarette aerosols among smokers: A cross-sectional study in six European countries of the EUREST-PLUS ITC Europe Surveys." Tobacco induced diseases vol. 16 (2018): A11. doi: https://doi.org/10.18332/tid/99117
Tigova O, Amalia B, Castellano Y, Fu M, Nogueira SO, Kyriakos CN, Mons U, Trofor AC, Zatoński WA, Przewoźniak K, Demjén T, Tountas Y, Quah ACK, Fong GT, Fernández E, Vardavas CI. Secondhand exposure to e-cigarette aerosols among smokers: A cross-sectional study in six European countries of the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis. 2019 Feb 15;16:A11. doi: 10.18332/tid/99117. eCollection 2018. PMID: 31516465; PMCID: PMC6661852.
Copy Download .nbib Format: NLM
Share it on

Tob Induc Dis. 2019 Feb 15;16:A11. doi: 10.18332/tid/99117. eCollection 2018.

Secondhand exposure to e-cigarette aerosols among smokers: A cross-sectional study in six European countries of the EUREST-PLUS ITC Europe Surveys.

Tobacco induced diseases

Olena Tigova, Beladenta Amalia, Yolanda Castellano, Marcela Fu, Sarah O Nogueira, Christina N Kyriakos, Ute Mons, Antigona C Trofor, Witold A Zatoński, Krzysztof Przewoźniak, Tibor Demjén, Yannis Tountas, Anne C K Quah, Geoffrey T Fong, Esteve Fernández, Constantine I Vardavas,

Affiliations

  1. Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain.
  2. Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
  3. School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
  4. European Network for Smoking and Tobacco Prevention (ENSP), Brussels, Belgium.
  5. University of Crete (UoC), Heraklion, Greece.
  6. Cancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  7. University of Medicine and Pharmacy 'Grigore T. Popa' Iasi, Iasi, Romania.
  8. Aer Pur Romania, Bucharest, Romania.
  9. Health Promotion Foundation (HPF), Warsaw, Poland.
  10. European Observatory of Health Inequalities, President Stanis?aw Wojciechowski State University of Applied Sciences, Kalisz, Poland.
  11. Maria Sk?odowska-Curie Institute-Oncology Center (MSCI), Warsaw, Poland.
  12. National and Kapodistrian University of Athens (UoA), Athens, Greece.
  13. Department of Psychology and School of Public Health and Health Systems, University of Waterloo (UW), Waterloo, Canada.
  14. Ontario Institute for Cancer Research, Toronto, Canada.

PMID: 31516465 PMCID: PMC6661852 DOI: 10.18332/tid/99117

Abstract

INTRODUCTION: Electronic cigarette (e-cigarette) use has grown significantly in some European Union (EU) Member States (MS). A better understanding of the exposure to secondhand e-cigarette aerosols (SHA) is necessary to develop and implement comprehensive regulations on e-cigarette use in public places. This study aims to assess the observation of e-cigarette use in public places, the self-reported exposure to SHA, and the level of users' comfort using e-cigarettes in the presence of others.

METHODS: This is a cross-sectional study of the Wave 1 International Tobacco Control 6 European Countries Survey recruiting adult smokers (n=6011) across six EU MS: Germany, Greece, Hungary, Poland, Romania, and Spain, within the EURESTPLUS Project. A descriptive analysis was conducted to estimate the prevalence (%) of observed e-cigarette use in different places, frequency of self-reported exposure to SHA, and level of comfort using e-cigarettes in the presence of others.

RESULTS: In all, 31.0% of smokers observed others using e-cigarette in public places, 19.7% in indoor places where smoking is banned, and 14.5% indoors at work. Almost 37% of smokers reported to be ever exposed to SHA, ranging from 17.7% in Spain to 63.3% in Greece. The higher prevalence of observed e-cigarette use and passive exposure to SHA was reported by smokers of younger age, of higher educational level and those being current or former e-cigarette users. Part (8.8%) of the smokers who were also e-cigarette users reported feeling uncomfortable using e-cigarettes in the presence of others.

CONCLUSIONS: A third of smokers from six EU MS reported being exposed to SHA. Prevalence differences were observed among the countries. In the context of scarce evidence on long-term health effects of exposure to SHA, precautionary regulations protecting bystanders from involuntary exposure should be developed.

Keywords: Europe; e-cigarette; passive exposure; secondhand aerosol; secondhand exposure

Conflict of interest statement

The authors declare that they have no competing interests, financial or otherwise, related to the current work. K. Przewoźniak reports grants and personal fees from the Polish League Against Cancer, o

References

  1. Eur J Public Health. 2003 Mar;13(1):56-60 - PubMed
  2. Prev Chronic Dis. 2013 May 16;10:E79 - PubMed
  3. Int J Tuberc Lung Dis. 2014 Jan;18(1):5-7 - PubMed
  4. Am J Prev Med. 2014 Apr;46(4):395-403 - PubMed
  5. Tob Control. 2015 Sep;24(5):442-8 - PubMed
  6. Nicotine Tob Res. 2014 Dec;16(12):1541-8 - PubMed
  7. Nicotine Tob Res. 2015 Feb;17(2):256-8 - PubMed
  8. BMJ. 2014 Sep 09;349:g5512 - PubMed
  9. Nicotine Tob Res. 2015 Feb;17(2):219-27 - PubMed
  10. Environ Res. 2014 Nov;135:76-80 - PubMed
  11. PLoS One. 2014 Dec 03;9(12):e114256 - PubMed
  12. BMJ Open. 2015 Mar 26;5(3):e007134 - PubMed
  13. Nicotine Tob Res. 2016 May;18(5):686-93 - PubMed
  14. Eur J Public Health. 2016 Apr;26(2):344-9 - PubMed
  15. BMJ Open. 2015 Nov 03;5(11):e009218 - PubMed
  16. BMC Public Health. 2016 Apr 14;16:327 - PubMed
  17. Tob Control. 2017 Jan;26(1):98-104 - PubMed
  18. Gac Sanit. 2016 Sep-Oct;30(5):366-9 - PubMed
  19. Public Health Res Pract. 2016 Apr 15;26(2): - PubMed
  20. Tob Control. 2017 Jul;26(4):440-445 - PubMed
  21. Am J Prev Med. 2017 Feb;52(2):e33-e66 - PubMed
  22. BMJ Open. 2017 Jan 19;7(1):e013150 - PubMed
  23. Tob Control. 2018 May;27(3):254-257 - PubMed
  24. Bull World Health Organ. 2017 Jul 1;95(7):540-541 - PubMed
  25. Environ Sci Technol. 2017 Aug 15;51(16):9271-9279 - PubMed
  26. Adv Exp Med Biol. 2018;1039:1-8 - PubMed
  27. Prev Med. 2017 Dec;105:10-14 - PubMed
  28. Addict Behav. 2018 Apr;79:219-225 - PubMed
  29. Tob Control. 2017 Dec 5;:null - PubMed
  30. Drug Alcohol Depend. 2018 Apr 1;185:142-148 - PubMed
  31. Gac Sanit. 2018 Oct 27;:null - PubMed

Publication Types